RecruitingNot ApplicableNCT06381115

App-Based Optimization of Long-Term CPAP Adherence and Quality of Life

An App-Based, Precision Medicine Approach to Optimize Long-Term CPAP Adherence and Quality of Life

Sponsor

Mayo Clinic

Enrollment

40 participants

Start Date

Jun 1, 2025

Study Type

INTERVENTIONAL

Conditions

Obstructive Sleep Apnea

Summary

The purpose of this study is to optimize the time of CPAP usage to at least 6 hours a night for 6 nights per week for people who have OSA with the help of a smartphone application called SmartWell24. This application aims to target CPAP adherence.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called SleepWell24 Application for people with obstructive sleep apnea. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALSleepWell24 Application

The SleepWell24 application will use connections with a Shelly smart plug and a Fitbit Charge 4 along with weekly questionnaires to monitor CPAP usage.

Locations(2)

Mayo Clinic in Arizona

Scottsdale, Arizona, United States

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06381115

Related Trials

Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation

NCT0744437227 locations

Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study

NCT048144203 locations

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy

NCT0722676554 locations

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

NCT0722568660 locations

Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)

NCT041799811 location